BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10936786)

  • 1. Intra-tumoral cytolytic cells: pattern of distribution in B-cell non Hodgkin s lymphoma.
    Perambakam S; Naresh K; Nerurkar A; Nadkarni J
    Pathol Oncol Res; 2000; 6(2):114-7. PubMed ID: 10936786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
    Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
    Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.
    Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE
    Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features.
    Felgar RE; Salhany KE; Macon WR; Pietra GG; Kinney MC
    Hum Pathol; 1999 Feb; 30(2):228-36. PubMed ID: 10029454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
    Chiang AK; Chan AC; Srivastava G; Ho FC
    Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative ultrastructural study of cytotoxic granules in nasal natural killer cell lymphoma, intestinal T-cell lymphoma, and anaplastic large cell lymphoma.
    Sadahira Y; Akisada K; Sugihara T; Hata S; Uehira K; Muraki N; Manabe T
    Virchows Arch; 2001 Mar; 438(3):280-8. PubMed ID: 11315625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.
    Kumar S; Krenacs L; Medeiros J; Elenitoba-Johnson KS; Greiner TC; Sorbara L; Kingma DW; Raffeld M; Jaffe ES
    Hum Pathol; 1998 Apr; 29(4):397-403. PubMed ID: 9563791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ detection of activated cytotoxic cells in follicular lymphomas.
    Leger-Ravet MB; Devergne O; Peuchmaur M; Solal-Celigny P; Brousse N; Gaulard P; Galanaud P; Emilie D
    Am J Pathol; 1994 Mar; 144(3):492-9. PubMed ID: 7510456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders.
    Kamarashev J; Schaerer L; Burg G; Schmid MH; Müller B; Kempf W
    J Cutan Pathol; 2001 Oct; 28(9):448-52. PubMed ID: 11553310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell subsets and natural killer-like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features.
    Gibson SE; Swerdlow SH; Felgar RE
    Hum Pathol; 2011 May; 42(5):679-87. PubMed ID: 21292303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. SWOG Central Repository Members.
    Diaz J; Tubbs R; Stoler M; Grogan T
    Leuk Lymphoma; 1993 Jan; 9(1-2):91-4. PubMed ID: 8477207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-rich large-B-cell lymphomas contain non-activated CD8+ cytolytic T cells, show increased tumor cell apoptosis, and have lower Bcl-2 expression than diffuse large-B-cell lymphomas.
    Felgar RE; Steward KR; Cousar JB; Macon WR
    Am J Pathol; 1998 Dec; 153(6):1707-15. PubMed ID: 9846961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system?
    Bladergroen BA; Meijer CJ; ten Berge RL; Hack CE; Muris JJ; Dukers DF; Chott A; Kazama Y; Oudejans JJ; van Berkum O; Kummer JA
    Blood; 2002 Jan; 99(1):232-7. PubMed ID: 11756176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas. Differences between high-grade and low-grade cases.
    Guidoboni M; Doglioni C; Laurino L; Boiocchi M; Dolcetti R
    Am J Pathol; 1999 Sep; 155(3):823-9. PubMed ID: 10487840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients.
    Alvaro-Naranjo T; Lejeune M; Salvadó-Usach MT; Bosch-Príncep R; Reverter-Branchat G; Jaén-Martínez J; Pons-Ferré LE
    Leuk Lymphoma; 2005 Nov; 46(11):1581-91. PubMed ID: 16236613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56+ putative natural killer cell lymphomas: production of cytolytic effectors and related proteins mediating tumor cell apoptosis?
    Ng CS; Lo ST; Chan JK; Chan WC
    Hum Pathol; 1997 Nov; 28(11):1276-82. PubMed ID: 9385933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.